#oral-immunotherapy

[ follow ]
#food-allergies #nhs #parenting #healthcare-access #clinical-stage-biotech #stat6-degrader #type-2-inflammation
Public health
fromwww.bbc.com
1 month ago

'I gave up my job due to the stress of my child's food allergies'

A mother left her job to care for her daughter with life-threatening food allergies due to ongoing stress and fear from severe allergic reactions.
Venture
from24/7 Wall St.
2 months ago

Kymera CEO Nello Mainolfi's Boldest Line Had Nothing to Do With the Earnings Miss

Kymera Therapeutics advanced the first IRF5-directed therapy into human trials and progressed KT-621, an oral STAT6 degrader showing efficacy comparable to dupilumab with potential to treat millions of undertreated Type 2 inflammatory disease patients.
[ Load more ]